Gestational changes in buprenorphine exposure: A physiologically‐based pharmacokinetic analysis

Abstract

PBPK model-based simulation may be a useful tool to optimize BUP pharmacotherapy during pregnancy, obviating the need to perform pharmacokinetic studies in each trimester and the postpartum period that normally require intensive blood sampling.